Blobet

Medicinal product

(Invented) name

Blobet

Active substance (s)

Metoprololio sukcinatas

Strength

47,5 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C07AB02, Metoprolol

Marketing authorisation holder

Zentiva k.s., Čekija

Date of authorisation

2024-07-10

Date of renewal

Documents

5493-95_pakuotes lapelis_2024-07-10.docx

5493_5494_5495_Blobet.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

SK/H/0298/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Metoprololio sukcinatas	47,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
114183	100295	1100295	lizdinė plokštelė	N30		Receptinis	LT/1/24/5494/001	Netiekiama	2025-01-09	2025-02-28	No	-	-
114184	100296	1100296	lizdinė plokštelė	N50		Receptinis	LT/1/24/5494/002	Netiekiama	-	-	No	-	-
114185	100297	1100297	lizdinė plokštelė	N100		Receptinis	LT/1/24/5494/003	Netiekiama	-	-	No	-	-
114186	100298	1100298	lizdinė plokštelė	N250		Receptinis	LT/1/24/5494/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-07-10	Registruotas